DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Immune Pharmaceuticals, Inc. 

150 Broadway
Suite 1801
New York  New York  10038  U.S.A.
Phone: 646-937-1941 Fax: n/a


SEARCH JOBS










 Company News
Immune Pharmaceuticals, Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 11/26/2014 8:57:09 AM
Immune Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 11/20/2014 12:32:26 PM
Immune Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock And Warrants To Purchase Common Stock 11/19/2014 3:40:25 PM
Immune Pharmaceuticals, Inc.'s CEO To Present On Personalized Medicine At The 2014 NY/ NJ CEO Biotech Conference 11/11/2014 8:34:41 AM
Immune Pharmaceuticals, Inc. Release: New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease 10/22/2014 8:01:23 AM
Immune Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial In Ulcerative Colitis 9/18/2014 8:28:02 AM
Immune Pharmaceuticals, Inc. Presenting At The 16th Annual Rodman & Renshaw Global Investment Conference, September 10, 2014 9/8/2014 8:42:58 AM
Immune Pharmaceuticals, Inc. Announces Approval For Listing On The NASDAQ Capital Market 8/19/2014 7:30:57 AM
Immune Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results And Provides Update On Bertilimumab Commencement Of Phase 2 Clinical Trials 8/14/2014 8:36:23 AM
Immune Pharmaceuticals, Inc. Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 7/30/2014 8:01:42 AM
12345